Trials / Completed
CompletedNCT00692055
Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- POZEN · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
We will evaluate the bioavailability of naproxen 375 mg in two formulations
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PN400 | naproxen 375 mg / esomeprazole 20 mg |
| DRUG | Naproxen | naproxen 375 mg |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-06-06
- Last updated
- 2008-09-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00692055. Inclusion in this directory is not an endorsement.